INTRODUCTION {#sec1-1}
============

Atrial fibrillation (AF) is the most common arrhythmic complication of coronary artery bypass grafting surgery (CABG). Depending on the type of cardiac surgery, its incidence varies between 30% and 50%.[@ref1] The exact factors affecting its incidence are largely unknown. Postoperative AF has been showed to increase both postoperative and 10-year mortality rates, with the latter being increased by 29%.[@ref2] Some studies have reported that elevated HbA1c levels preceding surgery are linked to the severity of adverse outcomes after CABG.[@ref3] An elevated HbA1c level is reportedly related to a greater incidence of cardiovascular events.[@ref4] We aimed to determine the association between preoperative hemoglobin A1c and AF after isolated off-pump coronary bypass grafting (OPCAB).

METHODS {#sec1-2}
=======

Seventy-two diabetic patients undergoing OPCAB at our hospital from January 2012 to June 2014 were retrospectively analyzed for AF. The study was approved by the hospital ethic committee. OPCAB was performed in all patients and a shift to cardiopulmonary bypass was not necessary for any patients. Baseline demographic and clinical data were available for all patients, and medical records were accessed for the initial medical data. We divided these patients into three groups (control of diabetic regulation was very good, good and bad) according to the preoperative HbA1c levels. The cutoff points for the groups were selected as follows: Low group; 4.5--5.4% (n =13), Medium group; 5.5--8% (n = 45), and high group: 8.1--11.5% (n =14). Continuous electrocardiographic monitoring via a bedside monitor at the intensive care unit and a telemetry unit at the hospital ward were carried out in all patients after completion of the surgery.

A 12-lead electrocardiogram was taken and evaluated by an experienced physician when the automatic alarm function detected an arrhythmic episode. HbA1c levels were measured before surgery by liquid chromatography. During the bypass surgery, multiple and complete coronary revascularization were attempted at all times, using a composite or sequential grafting in all cases. Arterial grafts in general, and in situ arterial grafts in particular, were used whenever possible. Continuous infusion of diltiazem (0.5-1. 0 µg/kg) was utilized to prevent arterial spasm during and within 24 hours after the operation, followed by oral diltiazem (90 mg/day), acetylsalicylic acid(100 mgr/day) and clopidogrel (75 mg/day) commenced at the next morning.

Anesthetic & surgical technique {#sec2-1}
-------------------------------

Intravenous fentanyl citrate, midazolam, and vecuronium bromide were employed for anesthesia induction while intravenously administered remifentanyl, vecuronium bromide and low concentrations of inhaled sevoflurane as necessary served for anesthesia maintenance. Heparin was administered to anticoagulated patients after harvesting bypass conduits. The activated clotting time was maintained at more than 250s. The off-pump technique was used for all patients. Intravenous administration of Magnesium (Mg levels were kept over 2 mgr/dl) and potassium were given (K levels were kept over 4 mgr/dl) before pericardiotomy was done for all patients.

Statistical Analysis {#sec2-2}
--------------------

Statistical analysis was performed on SPSS 15.0 for Windows software package with 95% confidence. Independent Sample t-test was used for the parametric features like age, BMI and HbA1c in the men and women. Kruskal Wallis H statistical analysis was used for the comparison between the non-parametric features in continuous variables of more than two groups. Relationships between variables were assessed by Pearson and Spearman correlation analysis. The effects of variables on postoperative AF occurrence were examined using logistic regression analysis. P \<0.05 was considered statistically significant.

RESULTS {#sec1-3}
=======

Demographic findings of the patient groups can be seen in [Table-I](#T1){ref-type="table"}. [Fig.1](#F1){ref-type="fig"} shows the distribution of HbA1c and the median value of HbA1c (25th--75th percentile) was 6.0 (5--7.5). AF occurred in 12 of 72 patients (16.6%) after surgery, most often on postoperative day 2 (75%), with 24.9% of occurrences on postoperative day 3. The incidences of postoperative AF were 15.3% (2/13) in the Low group, 4.4% (2/45) in the Median group, and 57.1% (8/14) in the High group. Three patients died at postoperative period in the High group (hospital mortality, P = 0.000) ([Table-I](#T1){ref-type="table"}).

###### 

Baseline characteristics & operative variables.

                                                          Preoperative HbA1C   P value                    
  --------------------------------------- --------------- -------------------- --------------- ---------- ---------
  Sex                                     Male/Female     7/6                  26/19           7/7        0,831\*
  Age                                     62,85±7,84      62,4±10,27           66,21±10,21     0,302\*    
  LVEF                                    (\<30)          0 (0)                2 (4,4)         4 (28,6)   0,910\*
  (30-50)                                 10 (76,9)       20 (44,4)            3 (21,4)                   
  (\>50)                                  3 (23,1)        23 (51,1)            7 (50)                     
  Chronic renal failure                   1 (7,7)         5 (11,1)             1 (7,1)         0,950      
  Hypertension                            10 (76,9)       36 (80)              11 (78,6)       0,922      
  Previous cerebrovascular disease        3 (23,1)        1 (2,2)              0 (0)           0,011      
  Chronic pulmonary disease               3 (23,1)        3 (6,7)              2 (14,3)        0,499      
  Peripheral vascular disease             1 (7,7)         2 (4,4)              0 (0)           0,319      
  Previous Myocardial infaction           1 (7,7)         12 (26,7)            4 (28,6)        0,213      
  Left atrial dimension (cm)              3,64±0,4        3,82±0,41            3,99±0,44       0,144      
  Number of anastomoses                   2,92±1,26       2,62±1,3             3,14±1,23       0,245      
  Number of arterial anastomoses          1,15±0,55       1,27±0,5             1,5±0,52        0,066      
  Number of vein grafts                   2±0,82          1,66±0,55            1,7±0,95        0,462      
  Preoperative used of Beta- Blockers     1 (7,7)         15 (33,3)            3 (21,4)        0,451      
  Use of Levosimendan                     1 (7,7)         3 (6,7)              5 (35,7)        0,025      
  Angiotensin converting inhibitors use   4 (30,8)        16 (35,6)            8 (57,1)        0,157      
  Use of Angiotensin receptor blockers    2 (15,4)        8 (17,8)             1 (7,1)         0,540      
  Use of Statins                          3 (23,1)        14 (31,1)            5 (35,7)        0,482      
  Use of Oral antidiabetics               11 (84,6)       24 (53,3)            10 (71,4)       0,521      
  Use of Insulin                          1 (7,7)         15 (33,3)            2 (14,3)        0,741      
  Use of Clopidogrel                      2 (15,4)        8 (17,8)             5 (35,7)        0,189      
  Endartterectomy                         2 (15,4)        4 (8,9)              0 (0)           0,150      
  Use of Intra-aortic balloon pump        0 (0)           0 (0)                4 (28,6)        0,001      
  Use of insulin during intensive care    7 (53,8)        18 (40)              10 (76,9)       0,243      
  Postoperative use of Dopamin            4 (30,8)        20 (44,4)            9 (64,3)        0,081\*    
  Postoperative use of Dobutamin          2 (15,4)        2 (4,4)              7 (50)          0,010\*    
  Postoperative use of Adrenalin          1 (7,7)         0 (0)                4 (28,6)        0,028\*    
  Postoperative use of Diltizem           1 (7,7)         8 (17,8)             5 (35,7)        0,066\*    
  Postoperative AF occurrence             0 (0)           4 (8,9)              8 (57,1)        0,000      
  Post-discharge AF                       0 (0)           1 (2,2)              4 (28,6)        0,003      
  Mortality                               0 (0)           0 (0)                3 (21,4)        0,005      
  Intubation time(hr)                     9,08±3,73       7,54±2,56            17,68±29,8      0,072      
  Chest tube drainage (ml)                457,69±181,25   432,22±183,76        539,29±301,39   0,658      
  Intensive care unit stay time(hr)       46,15±23,42     39,33±10,97          63,43±31,02     0,006      
  Mean time to AF occurrence (day)        \-              1,5±1                1,38±0,74       0,911      

Data are number (percent), mean ± standard deviation, or median \[25th--75th percentile\]. Low 4.5-5.4%; Median, 5.5-8%; High, \>8.%.

![Distribution of Preoperative HbA1c.](PJMS-32-59-g001){#F1}

In univariate logistic regression analysis between the presence of postoperative AF and variables like LVEF \<30 (p=0.015), preoperative MI history (p = 0.004), preoperative use of levosimendan (p = 0.003) and clopidogrel (p = 0.011), postoperative dopamine (P = 0.036), dobutamine (p = 0.000) and adrenaline use (p = 0.004), LA size (P = 0.002), 24-hour chest tube drainage (p = 0.029), length of stay in the ICU (p = 0.003) and preoperative HbA1c (p = 0.000) showed values were statistically significant (p \<0.05) ([Table-III](#T3){ref-type="table"}). Higher HbA1c levels were correlated with intraaortic balloon counter pulsation use (IABP) (p=0.01), preoperative cerebrovascular disease rate (p=0.011), use of preoperative levosimendan usage (p=0.025), use of postoperative dobutamine (p=0.01) and adrenalin (p=0.028) and longer intensive care unit stay (p=0.006). Correlation analysis showed that there is statistically significant correlation between preoperative HbA1C and occurrences of SVO (p = 0.020), postoperative AF with preoperative MI history (p = 0.002), Left atrial (LA) size (p = 0.000), preoperative use of levosimendan (p = 0.001), preoperative use of clopidogrel (p = 0.006), postoperative dopamine (p = 0.000) and dobutamine use (p = 0.000), IABP usage (p = 0.011), duration of extubation (p = 0.011), 24 hour chest tube drainage (p = 0.011), duration of ICU (p = 0.01) and hospital mortality (p = 0.000) (p \<0.05) ([Table-II](#T2){ref-type="table"}).

###### 

Correlation analysis of preoperative & postoperative variables with HbA1c values associated with AF.

                                      Preoperative HbA1C   Postoperative AF            
  ----------------------------------- -------------------- ------------------ -------- -------
  Previous cerebrovascular disease    -0,273               0,020              -0,108   0,364
  Previous Myocardial infaction       0,057                0,632              0,366    0,002
  Left atrial dimension (cm)          0,151                0,204              0,441    0,000
  Levosimendan                        0,201                0,090              0,394    0,001
  Clopidogrel                         0,089                0,458              0,321    0,006
  Postoperative used of Dopamin       0,081                0,501              0,262    0,026
  Postoperative used of Dobutamin     0,232                0,049              0,535    0,000
  Postoperative used of Adrenalin     0,253                0,032              0,464    0,000
  Use of Intra-aortic balloon pump    0,361                0,002              0,542    0,000
  Intubation time(hr)                 0,167                0,161              0,300    0,011
  Chest tube drainage (ml)            0,113                0,346              0,276    0,019
  Intensive care unit stay time(hr)   0,349                0,003              0,472    0,000
  Mortality                           0,303                0,010              0,466    0,000

###### 

All variables with the presence of postoperative AF in univariate logistic regression analysis.

                                         AF+ (n=12)     AF -- (n=60)    Odds Ratio (95% C.I.)   p                  
  -------------------------------------- -------------- --------------- ----------------------- ------------------ -------
  Sex                                    M/F            4/8             28/32                   1,75 (0,48-6,44)   0,400
  Age                                    65,92±11,1     62,68±9,6       1,04 (0,97-1,11)        0,299              
  LVEF                                   (\>50)         5 (41,7)        28 (46,7)               Referance          0,015
  (30-50)                                3 (25)         30 (50)         0,56 (0,12-2,56)        0,455              
  (\<30)                                 4 (33,3)       2 (3,3)         11,2 (1,6-78,4)         0,015              
  Chronic renal failure                  1 (8,3)        6 (10)          0,82 (0,09-7,49)        0,859              
  Hypertension                           11 (91,7)      46 (76,7)       3,35 (0,4-28,25)        0,267              
  Previous cerebrovascular disease       \- (-)         4 (6,7)         0 (0-)                  0,999              
  Chronic pulmonary disease              3 (25)         5 (8,3)         3,67 (0,74-18,08)       0,110              
  Peripheral vascular disease            \- (-)         3 (5)           0 (0-)                  0,999              
  Previous Myocardial infaction          7 (58,3)       10 (16,7)       7 (1,84-26,56)          0,004              
  Preoperative used of Beta- Blockers    5 (41,7)       14 (23,3)       2,35 (0,64-8,56)        0,196              
  Levosimendan                           5 (41,7)       4 (6,7)         10 (2,16-46,26)         0,003              
  Angiotensin converting inhibitors      6 (50)         22 (36,7)       1,73 (0,5-6,01)         0,391              
  Angiotensin receptor blockers          1 (8,3)        10 (16,7)       0,45 (0,05-3,93)        0,474              
  Statins                                4 (33,3)       18 (30)         1,17 (0,31-4,37)        0,819              
  Oral antidiabetics                     7 (58,3)       38 (63,3)       0,81 (0,23-2,86)        0,744              
  Insulin                                3 (25)         15 (25)         1 (0,24-4,18)           1,000              
  Clopidogrel                            6 (50)         9 (15)          5,67 (1,49-21,54)       0,011              
  Endartterectomy                        \- (-)         6 (10)          0 (0-.)                 0,999              
  Postoperative use of Dopamin           9 (75)         24 (40)         4,5 (1,1-18,34)         0,036              
  Postoperative use of Dobutamin         7 (58,3)       4 (6,7)         19,6 (4,24-90,67)       0,000              
  Postoperative use of Adrenalin         4 (33,3)       1 (1,7)         29,5 (2,92-297,9)       0,004              
  Postoperative use of Diltizem          1 (8,3)        13 (21,7)       0,33 (0,04-2,79)        0,308              
  Use of Intra-aortic balloon pump       4 (33,3)       \- (-)                                  0,999              
  Use of insulin during intensive care   9 (75)         26 (44,1)       3,81 (0,94-15,5)        0,062              
  Post-discharge AF                      5 (41,7)       \- (-)                                  0,999              
  Hospital Mortality                     3 (25)         \- (-)                                  0,999              
  Left atrial dimension (cm)             4,23±0,38      3,73±0,39       21,84 (3,25-146,71)     0,002              
  Number of anastomoses                  2,92±1,24      2,75±1,3        1,1 (0,69-1,77)         0,679              
  Number of arterial anastomoses         1,25±0,45      1,3±0,53        0,82 (0,23-2,94)        0,758              
  Number of vein grafts                  2±0,93         1,68±0,65       1,9 (0,64-5,64)         0,245              
  Intubation time(hr)                    18,83±32,25    7,98±2,86       1,13 (0,96-1,34)        0,153              
  Chest tube drainage (ml)               587,5±296,28   431,67±182,95   1 (1-1,01)              0,029              
  Intensive care unit stay time(hr)      67±32,14       40,9±14,51      1,05 (1,02-1,09)        0,003              
  Preoperative HbA1C                     8,58±1,38      6,31±1,06       3,92 (1,92-7,99)        0,000              

Values are odds ratio (95% confidence interval), LV, left ventricle; EF, Ejection fraction.

Corrected Bonferroni Mann Whitney U test was used to find out the correlation of HbA1c level and several clinical conditions like the use of dopamine and ICU durations between medial and high groups (p = 0.008, p=0.001 p\<0.016 respectively) ([Table-I](#T1){ref-type="table"}). The mortality was significantly higher in High group (n=3, 100%) compared to low and median groups.

When examined all variables of preoperative HbA1c groups, statistically significant differences were found between groups of postoperative AF, AF after discharge and hospital mortality (p\<0, 05) ([Table-I](#T1){ref-type="table"}).

DISCUSSION {#sec1-4}
==========

Association of OPCAB surgery with decreased incidence of AF was shown in a meta analysis and provided evidence that OPCAB surgery may be associated with a reduced incidence of postoperative AF than on-pump CPB techniques in a generalized population. The off-pump and on-pump groups had postoperative AF incidences of 19% (1612/8265) and 24% (1976/8240).[@ref5] Our study revealed that AF complicated 16.6% of off-pump operations. Limited number of patients in our study can be shown to be the main reason of this low rates. In a prospective cohort study of 3089 patients with and without diabetes, Halkos et al.[@ref6] showed a significant correlation between HbA1c and in-hospital mortality and postoperative morbidity. The rates of postoperative complications, e.g. renal failure and cerebrovascular accident, were higher in patients with HbA1c ≥ 8.6%. AF occurred in 20.9% of patients having an HbA1c of less than 7.0% vs. 15.1% in those with an HbA1c level equal to or greater than 7.0%. Patients with a poor glycemic control evidenced by an HbA1c ≥7% had more complications than those with an HbA1c of less than 7%. Similarly, in 101 diabetic subjects operated with off-pump CABG, Matsuura et al.[@ref7] found a postoperative AF rate of 29.7% for an HbA1c of less than 6.5% and 22.2% for an HbA1c that was greater than 6.5%. In our study 72 diabetic patients undergoing OPCAB were retrospectively analyzed. We divided these patients into three groups according to the preoperative HbA1c levels (Low group; 4.5--5.4%, Medium group; 5.5--8%, and high group: 8.1--11.5%). Corrected Bonferroni Mann Whitney U test was used to find out the correlation of HbA1c level and several clinical conditions like the use of dopamine, ICU durations and mortality rates between medial and high groups. As a reason for this result, all of the patients in a low group LVEF values greater than 30%. However, Matsuura et al the two groups did not differ significantly with regard to early and late postoperative mortality, wound dehiscence, number of anastomosis, use of bilateral internal thoracic arteries, and patency rates. On the other hand, in 805 diabetic subjects operated with OPCAB surgery, Kinoshita et al.[@ref8] reported that the lower group, the middle group, and the upper group had postoperative AF rates of 28.3%, 17.4%, and 12.5%, respectively. Postoperative AF was less likely when an elevated preoperative HbA1c was present. Our study demonstrated that the lower group, the middle group, and the upper group had postoperative AF incidences of 15.3%, 4.4%, and 57.1%, respectively. The risk of postoperative AF was greater with an elevated preoperative HbA1c. Dublin et al.[@ref9] demonstrated an elevated risk in parallel with HbA1c level in a population-based case control study conducted in 1410 patients with newly-diagnosed AF. Another population-based study in 75-year-old subjects similarly showed higher HbA1c levels in patients who developed AF.[@ref10] Diabetics with higher HbA1c levels also suffer a higher rate of perioperative myocardial infarction.[@ref6],[@ref11]. Our study also showed similar results in that higher HbA1c levels significantly associated with risk of death. Faritous et al.[@ref12] demonstrated that a higher incidence of IABP, massive bleeding, and multi-organ failure result from higher HbA1c levels. Morbidity, but not mortality, is increased by elevated HbA1c levels following CABG. We showed that elevated HbA1c level increased the likelihood of IABP use (p=0.01), rate of preoperative cerebrovascular disease (P=0.011), use of preoperative levosimendan (P=0.025), use of postoperative dobutamine (p=0.01) in conjunction with adrenaline (p=0.028), longer intensive care unit stay (p=0.006), postoperative and post-discharge AF, and mortality rate (p\<0, 05). Goksedef et al.[@ref13] reported that in 150 diabetic and non-diabetic patients enrolled in a prospective fashion the rates of postoperative mediastinitis and local sternal infection (P = 0.8) were not significantly altered by an HbA1c level of \>7%. On the other hand, Sato et al.[@ref14] in a prospective study of 273 diabetic and non-diabetic patients, demonstrated that diabetics with a HbA1c greater than 6.5% suffered significantly more postoperative complications (minor infections and a more labor-intensive hospital stay). Alserius et al.[@ref15] Prospectively investigated the relationship between HbA1c level and infection and mortality rates in 605 subjects. HbA1c level greater than 6% was associated with significantly increased incidence of superficial sternal wound infections and mortality.

Limitations of the study {#sec2-3}
------------------------

First, off-pump technique was performed at a single center. Second, it was not a randomized controlled study. Third, it solely used preoperative laboratory data including HbA1c level but not assessed postoperative HbA1c alterations.

CONCLUSION {#sec1-5}
==========

Our study showed that preoperative HbA1c level was associated with AF in diabetic patients undergoing OPCAB. In conclusion, preoperative HbA1c could be predicts the occurrence of postoperative AF after isolated off-pump CABG.
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